GlassScriptPhysician profile
Anupam Garg
NPI 1013944636
$9,809.86
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $162 · 2021: $283 · 2022: $54.61 · 2023: $58.36 · 2024: $8,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Food and Beverage | $292.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtual Incision Corporation | $8,000.00 | 2024 | Mira |
| Astellas Pharma US INC | $292.70 | 2023-2024 | Veozah |
| Abbvie INC. | $290.60 | 2019-2021 | |
| Hologic Sales and Service, LLC | $234.92 | 2019-2021 | |
| Therapeuticsmd, INC. | $207.97 | 2019-2020 | |
| Intuitive Surgical, INC. | $174.90 | 2019-2022 | |
| Allergan, INC. | $143.02 | 2019 | |
| Lupin INC. | $65.36 | 2019-2020 | |
| Roche Diagnostics Corporation | $49.09 | 2019 | |
| Avion Pharmaceuticals | $43.09 | 2019 | |
| Exeltis, USA INC. | $38.57 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $38.23 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.78 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $31.04 | 2019-2020 | |
| Radius Health, INC. | $26.14 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $24.06 | 2022 | |
| Ascend Therapeutics US, LLC | $23.96 | 2019 | |
| Merck Sharp & Dohme LLC | $18.29 | 2019 | |
| Mission Pharmacal Company | $16.81 | 2019 | |
| Coopersurgical, INC. | $16.15 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.89 | 2019 | |
| Minerva Surgical, INC | $12.74 | 2019 | |
| Duchesnay USA Incorporated | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anupam Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.